⌘K
Loading ticker…
Clover Health Investments, Corp · Financials · Insurance
As of 2026-06-26, Clover Health Investments, Corp (CLOV) has a 3-month relative strength percentile of 98 and a leadership percentile of 99 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 87. The current market Stance is 47 (Neutral). Sector: Financials, ranked 9 of 11. Average daily range 6.7%, relative volume 1.56×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 98, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
CLOV is held by 6 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $21M notional. Top 3 carry $47M.
Top 6 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $21M |
| IWMiShares Russell 2000 ETF | 0.02% | $18M |
| VXFVanguard Extended Market ETF | 0.01% | $8M |
| IWOiShares Russell 2000 Growth ETF | 0.05% | $6M |
| XHSState Street SPDR S&P Health Care Services ETF | 1.60% | $1M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | CLOV Jan avg: 19.60% median: 20.00% win: 75% σ: 25.11% n: 4 2022-04-12 → 2026-05-29 | CLOV Feb avg: -6.71% median: -8.13% win: 0% σ: 4.22% n: 4 2022-04-12 → 2026-05-29 | CLOV Mar avg: -17.36% median: -12.68% win: 0% σ: 12.85% n: 4 2022-04-12 → 2026-05-29 | CLOV Apr avg: 0.95% median: -12.60% win: 20% σ: 31.39% n: 5 2022-04-12 → 2026-05-29 | CLOV May avg: 25.12% median: 14.66% win: 60% σ: 34.22% n: 5 2022-04-12 → 2026-05-29 | CLOV Jun avg: -3.31% median: -2.61% win: 50% σ: 14.71% n: 4 2022-04-12 → 2026-05-29 (current) | CLOV Jul avg: 32.26% median: 35.09% win: 100% σ: 21.64% n: 4 2022-04-12 → 2026-05-29 | CLOV Aug avg: 6.59% median: -0.99% win: 50% σ: 21.63% n: 4 2022-04-12 → 2026-05-29 | CLOV Sep avg: -7.10% median: -5.17% win: 50% σ: 23.50% n: 4 2022-04-12 → 2026-05-29 | CLOV Oct avg: 10.67% median: 4.15% win: 50% σ: 26.42% n: 4 2022-04-12 → 2026-05-29 | CLOV Nov avg: -16.37% median: -16.31% win: 0% σ: 10.66% n: 4 2022-04-12 → 2026-05-29 | CLOV Dec avg: -10.19% median: -7.55% win: 25% σ: 13.67% n: 4 2022-04-12 → 2026-05-29 |